主办:上海医药工业研究院
   中国药学会
   中国化学制药工业协会
ISSN 1001-8255   CN 31-1243/R   ZYGZEA

Current Issue

  • Select all
    |
    Perspectives & Review
  • Perspectives & Review
    WANG Jiahui , , HAN Bo, , ZHANG Zixue , , ZHANG Qingwei ,
    Abstract ( )   Knowledge map   Save
    In 2025, FDA approved 46 new drugs for marketing, including 31 small molecule drugs and 15 biological products. Based on FDA-approved drug labeling, related databases, patents, and published literature, this review describes the chemical name, original research company, compound patent, time to market, indications, mechanism of action, dosage form and strengths, adverse effects and synthesis routes of those small molecule drugs, and the basic information about biological products.
  • Perspectives & Review
    YI Xuefu , ZHU Yijun
    Abstract ( )   Knowledge map   Save
    Enzymatic catalysis, which uses enzymes as the core catalyst, has been widely applied in the synthesis of chiral drugs due to its advantages of mild reaction conditions, high stereoselectivity, and low environmental pollution. Common types of biocatalytic reactions include ketoreductase, imine reductase(IRED), transaminase(TA), hydrolase, and amino acid dehydrogenase. This paper focuses on the mechanisms of IRED and TA, as well as their applications in the synthesis of 15 marketed chiral amine drugs(with 6 cases having achieved large-scale production). It also provides an outlook on the diversiffed applications and future development directions of biological enzyme catalysis to address the opportunities and challenges of this technology in the future.
  • Perspectives & Review
    YIN Xinyu, LI Yuting, HE Jun
    Abstract ( )   Knowledge map   Save
    Liposomes are widely used in drug delivery due to their excellent biocompatibility and surface modiffability. Functionalized liposomes represent a key research direction in liposome technology. This review summarizes surface modiffcation strategies for functionalized liposomes, including stimuli-responsive(pH value, redox, enzyme, and thermal/magnetic/optical/acoustic triggers), active targeting(antibody/aptamer/peptide), and biomimetic coatings, along with their applications in drug delivery. It also analyzes the limitations of functionalized liposomes, aiming to provide a reference for further research and application in this ffeld.
  • Perspectives & Review
    LIU Wenying
    Abstract ( )   Knowledge map   Save
    Copper is an indispensable trace element in the human body. The process of cell death caused by the imbalance of copper homeostasis in the body is called cuproptosis. Taking advantages of the high biological activity of tumor tissues and their large uptake of copper, researchers use copper-containing drug delivery system to effectively kill tumor cells and regulate the tumor microenvironment. According to the cuproptosis theory, constructing copper-containing drug delivery systems for the treatment of major diseases such as tumor therapy is of practical significance. This paper reviews the copper-containing drug delivery system based on the cuproptosis theory, focusing on the relationship between copper metabolism, copper homeostasis and carcinogenesis.
  • Paper
  • Paper
    WANG Shaolin, GUO Lihong, XU Jie, LI Wei, ZHAI Lihai
    Abstract ( )   Knowledge map   Save
    During the investigation of the stability of baricitinib API, various photodegradation impurities were found. Seven photodegradation impurities were detected and analyzed by LC-MS, namely 4-amino-6-[1-[3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl]-1H-pyrazol-4-yl]pyrimidine-5-carboxylic acid(PDI-1), 2-[3-[4-[6-amino-5-(hydroxymethyl)pyrimidin-4-yl]-1H-pyrazol-1-yl]-1-(ethylsulfonyl)azetidin-3-yl]acetonitrile(PDI-2),2-[3-[4-(6-aminopyrimidin-4-yl)-1H-pyrazol-1-yl]-1-(ethylsulfonyl)azetidin-3-yl]acetonitrile(PDI-3), [4-amino-6-[1-[3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl]-1H-pyrazol-4-yl]pyrimidin-5-yl]methyl formate(PDI-4), 2-[3-[4-(6-amino-5-formylpyrimidin-4-yl)-1H-pyrazol-1-yl]-1-(ethylsulfonyl)azetidin-3-yl]acetonitrile(PDI-5), N-[6-[1-[3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl]-1H-pyrazol-4-yl]pyrimidin-4-yl]formamide(PDI-6) and N-[6-[1-[3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl]-1H-pyrazol-4-yl]-5-formylpyrimidin-4-yl]formamide(PDI-7). And their synthesis and NMR structural characterization were completed. Among them, impurities PDI-2, PDI-4 and PDI-5 were reported for the ffrst time. This work might provide some reference for the quality research, storage conditions and product development of 1.
  • Paper
    ZHANG Na , , ZHU Zhongsong, , LIU Zhong , ZHANG Guimin , ZHAO Lili ,
    Abstract ( )   Knowledge map   Save
    Anti-T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain(TIGIT) monoclonal antibodies hold great potential for the treatment of malignant tumors, although their efffcacy still needs to be improved. In this study, a mouse phage antibody library was constructed, and 11 monoclonal antibodies were screened successfully. Two high-affinity blocking antibodies(SY15-84 and SY15-P2-001) were subjected to humanization modiffcation, and their pharmacodynamic activities were evaluated using a mouse solid tumor model. The results revealed that the humanized antibodies, SY15-84-3 and SY15-P2-001-3, had higher afffnity and binding capacity compared with the parental antibodies, as well as robust bioactivity in vitro. They could efffciently disrupt the TIGIT-CD155 inhibitory axis, and reactivate the CD226-CD155 signaling pathway. Both antibodies demonstrated signiffcant anti-tumor effects, with relative tumor inhibition rates of 88.19% and 93.50% , respectively. This study provides data support for the development of anti-TIGIT drugs.
  • Paper
    ZHOU Zhijun , YUE Shenglan , ZHOU Xiaoyan , CHEN Limei , SHAN Jing , HU Yong
    Abstract ( )   Knowledge map   Save
    This study developed a preparation method for semi-ffnished products of 10% human varicella-zoster immunoglobulin(VZIG) for intravenous injection. First, an ELISA method was used to quantitatively detect VZIG antibody potency. Plasma units from healthy donors were screened based on their measured ELISA potency, and small mixed-plasma samples with different ELISA potency were prepared. Then, a membrane antigen immunofluorescence antibody detection(namely fluorescence-antibody-to-membrane-antigen, FAMA) method was performed to detect the corresponding potency, and the correlation between the two detection methods was compared. Meanwhile, based on the distribution of ELISA potency in the donor population, a retrospective screening approach replaced universal screening to optimize qualiffed plasma collection. Finally, qualiffed plasma units with different ELISA potency were pooled as starting material, and two batches of VZIG intermediate product were prepared using a full chromatography puriffcation process. The results showed that there was a strong correlation between FAMA and ELISA potency[correlation coefffcient(r) was 0.976, coefffcient of determination(R²) was 0.951 7, P<0.000 1]. High antibody positivity rate to VZIG (94.18% ) but low proportion of high-potency plasma(ELISA potency ≥ 3.000 IU/mL) was found in healthy donors. Retrospective screening significantly reduced testing costs and collection time. Compared to the traditional cold ethanol fractionation process, the full chromatographic process signiffcantly lowered the residual levels of anti-A, anti-B, immunoglobulin(Ig) A, and IgM in the semi-ffnished product with similar IgG subclass distributions and undetectable sodium caprylate. Other key quality indicators complied with the requirements of ChP 2025 edition. The semi-ffnished products had FAMA potency ≥ 50.000 IU/mL and speciffc activities over 0.5 IU/mL, meeting EP 11.0 standards for intravenous varicella immunoglobulin.
  • Paper
    CHEN Shiyun, , GAO Yonghao , HE Yong, , YU Yanying,
    Abstract ( )   Knowledge map   Save
    A randomized, two-period cross-over design was conducted to evaluate the pharmacokinetics and bioequivalence of two brands of tofacitinib citrate extended-release tablets in healthy volunteers. Following a single oral dose of the test(T) and reference(R) preparations, plasma concentrations of tofacitinib at different time points were measured using a validated LC-MS/MS method. The main pharmacokinetic parameters of T and R preparations were calculated and listed as follows: under fasting conditions, cmax were (53.84±11.48) and (55.54±13.22)ng/mL, AUC0→t were (379.75±79.20) and (376.76±90.97)ng·h·mL–1 ,AUC0→∞ were (383.30±79.06) and (387.94±82.67)ng·h·mL–1 . Under fed conditions, cmax were (72.09±16.39) and (69.49±16.52)ng/mL,AUC0→t were (385.10±85.75) and (386.83± 89.69)ng·h·mL–1 ,AUC0→∞ were (391.76±87.17) and (391.29±96.47)ng·h·mL–1 . The results showed that under fasting and fed conditions, there were no signiffcant differences in above parameters between T and R preparations(P>0.05). The geometric mean ratios of the main pharmacokinetic parameters for T and R preparations both fell within the 90% confdence interval of 80.00% - 125.00% . No serious adverse events were observed during the study, all reported adverse events were Grade 1 in severity. These results indicated that the T and R preparations were bioequivalent in Chinese healthy volunteers with acceptable safety and tolerability, supporting the potential for domestic substitution of tofacitinib citrate extended-release tablets.
  • Paper
    SHI Yanshun, NING Baoming, ZHU Qihang, WANG Teng, WANG Xuezhong
    Abstract ( )   Knowledge map   Save
    Based on ultraviolet spectral data from the release processes of ibuprofen sustained-release capsules produced by two manufacturers, this study aimed to develop a modelling approach for real-time online monitoring of drug release behavior using an online UV spectrophotometer. The research focused on the application of a genetic algorithm for automatic feature wavelength selection and partial least squares(PLS) modelling. During the release tests, multiple samples were taken and analyzed offline by HPLC to determine ibuprofen content. A total of 165 release solution samples were collected from 10 experiments, with their results serving as calibration data for the online UV method and reference values for validation. The performance of full-spectrum PLS models was compared with that of PLS models built based on feature wavelengths selected by the genetic algorithm. The results showed that the PLS model based on genetically selected feature wavelengths performed better. The optimal model demonstrated a training set prediction performance with adjusted R-squared(Rc 2) of 0.992 6 and a root mean square error(RMSEC) of 0.017 1. The average relative error for the test set was 3.52% . The model predictions showed good agreement with offline HPLC results. A paired t-test was used to compare the release behaviors of the capsules from the two manufacturers, and the results showed a statistically significant difference(P<0.05). Furthermore, the cumulative release rates of products from both manufacturers were found to be below the corresponding pharmacopoeial requirements in some cases, which deserved attention in pharmaceutical quality control.
  • Paper
    WANG Yan, REN Zhiyong, SHI Zhaoyong, WU Tong, OUYANG Danwei,
    Abstract ( )   Knowledge map   Save
    An ultra-high performance liquid chromatography fingerprint and multi-component determination method were established for Danshen injection(DSI), and chemical pattern recognition was combined to evaluate the quality of different batches of DSI. The separation was performed on a Waters ACQUITY UPLC HSS T3 column(2.1 mm×100 mm, 1.8 μm) with gradient elution using 0.5% phosphoric acid aqueous solution and acetonitrile as the mobile phases at a flow rate of 0.4 mL/min. The column temperature was 40 ℃ and the detection wavelength was 286 nm. The fingerprints of 13 batches of DSI were established, with inter-batch similarity values all greater than 0.98. A total of 25 common peaks were calibrated, and 14 of them were identified by reference substances, namely 5-hydroxymethylfurfural(1), salvianic acid A sodium(2), protocatechuic acid(3), protocatechualdehyde(4), caffeic acid(5), isoferulic acid(6), salvianolic acid F(7), salvianolic acid D(8), rosmarinic acid(9), salvianolic acid E(10), lithospermic acid(11), salvianolic acid B(12), salvianolic acid A(13) and salvianolic acid Y(14). The above 14 components were subjected to multi-component quantitative analysis, and principal component analysis(PCA) and orthogonal partial least squares-discriminant analysis(OPLS-DA) were applied to screen out the main differential components, which were 1, 3, 6, 7, 9, 12 and 13. The results showed that DSI from different batches exhibited good quality stability, and the established fingerprint and multicomponent determination method were stable and reliable, which could provide a scientific basis for quality evaluation and standard establishment.
  • Paper
    SONG Dandan, WANG Xiuli, SHANG Yujun, ZHANG Qian, GAO Yu,
    Abstract ( )   Knowledge map   Save
    A laser scattering method for determining the particle size distribution of pramipexole dihydrochloride(1) bulk drug was established and validated. A laser particle size analyzer with dry dispersion system and standard Venturi tube was used. The parameters were set as follows: refraction index of 1.52, absorption of 0.01, dispersing pressure of 200 kPa, feed rate of 30% , background and sample measurement time of 10 s, obscuration range of 0.5% - 5.0% , and slit width of 1.5 mm. The RSD values for repeatability and intermediate precision were all less than 5% . For durability, the RSD values of d(0.5) were less than 5% , and the RSDs of d(0.1) and d(0.9) were less than 10% . This method is easy to operate, with high accuracy, good repeatability and durabilIty, can be used to determine the particle size distribution of 1 bulk drug, providing a reference for particle size control in drug development and production.
  • Paper
    QU Xilong, KONG Hexin, FENG Zhong, ZHANG Guimin,
    Abstract ( )   Knowledge map   Save
    A HPLC method was established for the simultaneous determination of seventeen related substances (2 - 18) in brexpiprazole(1) bulk drug. Separation was performed on a YMC Pack ODS-AQ column(4.6 mm×250 mm, 5 μm) with 0.02 mol/L potassium dihydrogen phosphate solution(adjusting pH to 2.5 with phosphoric acid) as mobile phase A and acetonitrile as mobile phase B in the gradient elution mode. The flow rate was 1.0 mL/min, the detection wavelength was 215 nm, the column temperature was 30 ℃ , and the injection volume was 10 μL. The correction factors of impurities 2 - 18 to the principal component were determined, and the main component self-comparison method with correction factors was established to determine seventeen known impurities. The results showed that the separation between the main component and various impurities was good, and it was linear for the main component and various impurities in the corresponding mass concentration ranges. The LOQs of 1 - 18 were 20.14 - 82.63 ng/mL, and the LODs were 6.71 - 27.54 ng/mL. The average recoveries(n=9) of 2 - 18 were 91.66% - 101.83% , with the RSDs of 0.49% - 1.45% . The established method can be used for the determination of the related substances in 1 with high accuracy, good sensitivity and good specificity, repeatability.
  • Paper
    LI Dan, XU Xu, ZHANG Xiao, LU Shanshan, SUN Chunyan
    Abstract ( )   Knowledge map   Save
    A reversed-phase high-performance liquid chromatography(RP-HPLC) method was established for the simultaneous determination of p-fluoro isomer(2) and enantiomer(3) in safinamide mesylate(1). Separation was performed on a CHIRALPAK IG-3 chiral column (4.6 mm×250 mm,3 μm) with a mobile phase consisting of 0.05 mol/L ammonium bicarbonate solution and methanol at a volume ratio of 10 ∶90 under isocratic elution mode. The detection wavelength was set at 226 nm, the flow rate was 0.5 mL/min, and the column temperature was maintained at 15 ℃ . The methodological studies showed that 2 and 3 had good linearity in the ranges of 0.16 - 1.62 and 0.16 - 1.57 μg/mL, respectively(r>0.99). Both the limit of detection(LOD) and limit of quantitation(LOQ) were determined to be 0.02 and 0.16 μg/mL, respectively. The average recoveries(n=9) of compounds 2 and 3 were 102.0% and 92.1% , with RSDs of 5.9% and 4.2% , respectively. This method is accurate, reliable and highly sensitive, which can be applicable for the quantitative determination of the two isomeric impurities in 1.
  • Pharmaceutical Management & Information
  • Pharmaceutical Management & Information
    XUAN Ze, YAO Ying, JIANG Zhijie, PANG Yihui, LIU Huan, XIE Langui
    Abstract ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    MA Yan, WANG Heqin, YANG Le, LU Zirong, GUO Qian
    Abstract ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    WU Bin, CHEN Jianfen, LI Junli, SONG Xuejie
    Abstract ( )   Knowledge map   Save